Drug-coated stent for the treatment of coronary artery disease
Vietnam·Risk Class TTBYT Loại D·Agent™ MONORAIL Paclitaxel-Coated PTCA Balloon Catheter·Hemoteq AG·Registered Oct 02, 2024- Analysis ID
- 2402667ĐKLH/BYT-HTTB
- Submission ID
- 000.00.04.G18-221011-0016
- Product Type
- Agent™ MONORAIL Paclitaxel-Coated PTCA Balloon Catheter
- Product Code
- Theo phụ lục
- Manufacturer
- Hemoteq AG
- Manufacturer Country
- Theo theo phụ lục
- Product Owner
- Hemoteq AG
- Authorized Representative
- CÔNG TY TNHH BOSTON SCIENTIFIC VIỆT NAM
- Intended Use
- The Paclitaxel-Eluting Vascular Bonding Agent is indicated for the treatment of in-stent restenosis (ISR) and de novo / small vessel disease in PTCA (percutaneous transluminal coronary angioplasty).
- Registration Date
- Oct 02, 2024
Companies providing products similar to "Drug-coated stent for the treatment of coronary artery disease"
Recently registered similar products
Access comprehensive regulatory information for Drug-coated stent for the treatment of coronary artery disease in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2402667ĐKLH/BYT-HTTB and manufactured by Hemoteq AG. The authorized representative in Vietnam is CÔNG TY TNHH BOSTON SCIENTIFIC VIỆT NAM.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Theo theo phụ lục, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.